FDx Advisors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $394K | Buy |
+1,335
| New | +$397K | 0.13% | 109 |
|
|
2025
Q4 | – | Sell |
-890
| Closed | -$236K | – | 105 |
|
|
2025
Q3 | $236K | Buy |
+890
| New | +$242K | 0.07% | 159 |
|
|
2024
Q2 | – | Sell |
-4,892
| Closed | -$1.05M | – | 225 |
|
|
2024
Q1 | $1.05M | Buy |
4,892
+878
| +22% | +$184K | 0.16% | 128 |
|
|
2023
Q4 | $845K | Buy |
4,014
+2,694
| +204% | +$575K | 0.07% | 295 |
|
|
2023
Q3 | $264K | Sell |
1,320
-1,072
| -45% | -$213K | 0.02% | 518 |
|
|
2023
Q2 | $443K | Buy |
2,392
+715
| +43% | +$132K | 0.02% | 479 |
|
|
2023
Q1 | $282K | Hold |
1,677
| – | – | 0.01% | 595 |
|
|
2022
Q4 | $282K | Buy |
+1,677
| New | +$291K | 0.01% | 595 |
|
|
2022
Q3 | – | Sell |
-1,854
| Closed | -$380K | – | 745 |
|
|
2022
Q2 | $380K | Buy |
1,854
+179
| +11% | +$37.9K | 0.01% | 553 |
|
|
2022
Q1 | $398K | Sell |
1,675
-5
| -0.3% | -$1.17K | 0.01% | 567 |
|
|
2021
Q4 | $384K | Buy |
1,680
+139
| +9% | +$30.6K | 0.01% | 616 |
|
|
2021
Q3 | $298K | Sell |
1,541
-558
| -27% | -$113K | 0.01% | 669 |
|
|
2021
Q2 | $446K | Sell |
2,099
-225
| -10% | -$47.5K | 0.01% | 538 |
|
|
2021
Q1 | $475K | Buy |
2,324
+506
| +28% | +$99.7K | 0.02% | 480 |
|
|
2020
Q4 | $331K | Buy |
+1,818
| New | +$309K | 0.01% | 540 |
|
|
2020
Q3 | – | Sell |
-2,427
| Closed | -$394K | – | 618 |
|
|
2020
Q2 | $394K | Buy |
+2,427
| New | +$435K | 0.02% | 385 |
|
|
2020
Q1 | – | Sell |
-1,395
| Closed | -$280K | – | 535 |
|
|
2019
Q4 | $280K | Buy |
1,395
+41
| +3% | +$8.41K | 0.02% | 507 |
|
|
2019
Q3 | $286K | Buy |
+1,354
| New | +$283K | 0.02% | 494 |
|
|
2019
Q1 | – | Sell |
-1,524
| Closed | -$287K | – | 787 |
|
|
2018
Q4 | $287K | Sell |
1,524
-767
| -33% | -$142K | 0.02% | 426 |
|
|
2018
Q3 | $390K | Buy |
+2,291
| New | +$386K | 0.01% | 604 |
|
|
2017
Q1 | – | Sell |
-5,322
| Closed | -$614K | – | 1129 |
|
|
2016
Q4 | $614K | Buy |
+5,322
| New | +$592K | 0.02% | 693 |
|
|
2016
Q1 | – | Sell |
-20,200
| Closed | -$1.83M | – | 903 |
|
|
2015
Q4 | $1.83M | Sell |
20,200
-4,037
| -17% | -$380K | 0.08% | 207 |
|
|
2015
Q3 | $2.25M | Buy |
24,237
+658
| +3% | +$62.5K | 0.19% | 100 |
|
|
2015
Q2 | $2.18M | Buy |
23,579
+19,579
| +489% | +$1.83M | 0.11% | 159 |
|
|
2015
Q1 | $378K | Buy |
+4,000
| New | +$371K | 0.01% | 1098 |
|
|
2014
Q4 | – | Sell |
-6,234
| Closed | -$498K | – | 900 |
|
|
2014
Q3 | $498K | Sell |
6,234
-1,456
| -19% | -$110K | 0.03% | 592 |
|
|
2014
Q2 | $546K | Buy |
7,690
+4,122
| +116% | +$290K | 0.04% | 544 |
|
|
2014
Q1 | $264K | Buy |
3,568
+6
| +0.2% | +$453 | 0.02% | 654 |
|
|
2013
Q4 | $279K | Buy |
+3,562
| New | +$279K | 0.03% | 552 |
|
Other funds holding CME
VCM
VPM
FDx Advisors's CME Position: Q1 2026 in Review
FDx Advisors opened a new position in CME Group (CME) in Q1 2026: 1,335 shares worth $394K. The stake represents 0.13% of the portfolio and ranks #109 among its holdings. This is a return to the name: FDx Advisors previously reported a position in CME as recently as Q3 2025.
FDx Advisors first reported a position in CME in Q4 2013 and has held it in 29 quarters since. The position peaked at $2.25M in Q3 2015. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- FDx Advisors held 1,335 shares of CME Group worth $394K as of Q1 2026.
- CME Group was a new FDx Advisors position in Q1 2026.
- CME Group made up 0.13% of FDx Advisors's portfolio in Q1 2026, its #109 holding.
- FDx Advisors first reported a position in CME Group in Q4 2013 and has held it in 29 quarters since.
- FDx Advisors's CME Group position peaked at $2.25M in Q3 2015.
- 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on FDx Advisors's 13F filing for Q1 2026, filed 1 May 2026.